Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Archives

You are currently viewing the 2004 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: LYRICA

« Back to Dashboard

Summary for Tradename: LYRICA

Patents:0
Applicants:1
NDAs:1
Suppliers: see list5
2013 Sales:$2,415,254,000

Clinical Trials for: LYRICA

A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy
Status: Completed Condition: Diabetic Neuropathy

Role of Pregabalin in Treatment of Post-Op Pain in Fracture Patients
Status: Completed Condition: Post-operative Pain

Pregabalin on Interleukin-6 Levels in Living Donor Kidney
Status: Completed Condition: Pain

A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome
Status: Recruiting Condition: Irritable Bowel Syndrome

Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures
Status: Terminated Condition: Epilepsies, Partial

Pregabalin and Orofacial Neuropathic Pain
Status: Terminated Condition: Neuralgia; Orofacial Pain

Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)
Status: Enrolling by invitation Condition: Neuralgia

Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan)
Status: Enrolling by invitation Condition: Neuropathic Pain

Effect of Oral Pregabalin on Spinal Neurotransmitters in Patients Undergoing Knee Replacement
Status: Completed Condition: PAIN

The Effects of Pregabalin on Postoperative Pain After Cardiac Surgery
Status: Recruiting Condition: Postoperative Pain

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Pfizer Global
LYRICA
pregabalin
CAPSULE; ORAL021446Dec 30, 2004RXNo<disabled><disabled>
Pfizer Global
LYRICA
pregabalin
CAPSULE; ORAL021446Dec 30, 2004RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: LYRICA

Drugname Dosage Strength RLD Submissiondate
pregabalinOral Solution20 mg/mLLyrica5/19/2010
pregabalinCapsules25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mgLyrica12/30/2008
« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc